These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36649919)
1. Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients. Lee J; Kim HR; Heo JE; Jang WS; Lee KS; Kang SK; Han H; Choi YD World J Mens Health; 2023 Oct; 41(4):892-899. PubMed ID: 36649919 [TBL] [Abstract][Full Text] [Related]
2. Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment. Siena G; Mari A; Canale A; Mondaini N; Chindemi A; Greco I; Saleh O; Serni S; Nicita G; Minervini A; Carini M J Sex Med; 2018 Feb; 15(2):120-123. PubMed ID: 29425663 [TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment. Loeb S; Folkvaljon Y; Robinson D; Schlomm T; Garmo H; Stattin P Eur Urol; 2016 Nov; 70(5):824-828. PubMed ID: 26743040 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Bhat KRS; Covas Moschovas M; Sandri M; Noel J; Reddy S; Perera R; Rogers T; Roof S; Patel VR Eur Urol Focus; 2022 Sep; 8(5):1192-1197. PubMed ID: 34736871 [TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence. Jo JK; Kim K; Lee SE; Lee JK; Byun SS; Hong SK Ann Surg Oncol; 2016 May; 23(5):1760-7. PubMed ID: 26717939 [TBL] [Abstract][Full Text] [Related]
9. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis. Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436 [TBL] [Abstract][Full Text] [Related]
10. Retzius Sparing Robot-Assisted Radical Prostatectomy Conveys Early Regain of Continence over Conventional Robot-Assisted Radical Prostatectomy: A Propensity Score Matched Analysis of 1,863 Patients. Lee J; Kim HY; Goh HJ; Heo JE; Almujalhem A; Alqahtani AA; Chung DY; Chang K; Choi YD; Rha KH J Urol; 2020 Jan; 203(1):137-144. PubMed ID: 31347951 [TBL] [Abstract][Full Text] [Related]
11. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis. Limoncin E; Gravina GL; Corona G; Maggi M; Ciocca G; Lenzi A; Jannini EA Andrology; 2017 Sep; 5(5):863-872. PubMed ID: 28787547 [TBL] [Abstract][Full Text] [Related]
12. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months. Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864 [TBL] [Abstract][Full Text] [Related]
13. Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step Guide. Egan J; Marhamati S; Carvalho FLF; Davis M; O'Neill J; Lee H; Lynch JH; Hankins RA; Hu JC; Kowalczyk KJ Eur Urol; 2021 Jun; 79(6):839-857. PubMed ID: 32536488 [TBL] [Abstract][Full Text] [Related]
14. Is there a relationship between phosphodiesterase type 5 inhibitors and biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis. He Q; Liao BH; Xiao KW; Zhou L; Feng SJ; Li H; Wang KJ Int Urol Nephrol; 2018 Dec; 50(12):2113-2121. PubMed ID: 30232722 [TBL] [Abstract][Full Text] [Related]
16. Impact of penile rehabilitation with phosphodiesterase-5 inhibitors on recovery of erectile function in patients undergoing robot-assisted radical prostatectomy: A propensity score-matched analysis. Kimura Y; Honda M; Teraoka S; Yumioka T; Iwamoto H; Morizane S; Hikita K; Takenaka A Int J Urol; 2021 Jun; 28(6):637-642. PubMed ID: 33663015 [TBL] [Abstract][Full Text] [Related]
17. Postoperative functional and cancer control evaluation of conventional and Retzius-sparing robot-assisted radical prostatectomy: Comparison of selected cases by propensity score matching. Kadono Y; Nohara T; Kawaguchi S; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Shigehara K; Izumi K; Mizokami A Prostate; 2023 Jun; 83(8):773-780. PubMed ID: 36879364 [TBL] [Abstract][Full Text] [Related]
18. Sexual Satisfaction in Men Suffering From Erectile Dysfunction After Robot-Assisted Radical Prostatectomy for Prostate Cancer: An Observational Study. Albers LF; Tillier CN; van Muilekom E; van Werkhoven E; Elzevier HW; van Rhijn BWG; van der Poel HG; Hendricksen K J Sex Med; 2021 Feb; 18(2):339-346. PubMed ID: 33358558 [TBL] [Abstract][Full Text] [Related]
19. Matched comparison of robot-assisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients. Busch J; Gonzalgo ML; Leva N; Ferrari M; Cash H; Kempkensteffen C; Hinz S; Miller K; Magheli A World J Urol; 2015 Mar; 33(3):397-402. PubMed ID: 24853030 [TBL] [Abstract][Full Text] [Related]
20. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy. Kimura M; Caso JR; Bañez LL; Koontz BF; Gerber L; Senocak C; Donatucci CF; Vujaskovic Z; Moul JW; Polascik TJ BJU Int; 2012 Dec; 110(11 Pt C):E931-8. PubMed ID: 22520165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]